z-logo
open-access-imgOpen Access
Differences in rates of tyrosine aminotransferase deinduction with cyclic AMP and glucocorticoids.
Author(s) -
Elaine J. Lewis,
P Calie,
Wesley D. Wicks
Publication year - 1982
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.79.19.5778
Subject(s) - tyrosine aminotransferase , inducer , glucocorticoid , enzyme , enzyme inducer , de novo synthesis , tyrosine , messenger rna , protein biosynthesis , medicine , endocrinology , biology , biochemistry , chemistry , gene
As an indirect test of the possibility that cyclic AMP produces its stimulatory effects on the synthesis of tyrosine aminotransferase (L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5) by stabilizing its mRNA, the kinetics of decline in the rate of synthesis of this enzyme was measured in rat hepatoma cells following inducer removal or addition of RNA synthesis inhibitors. In all cases in which cells were previously exposed to cyclic AMP, the decline in enzyme synthesis after removal of inducer or addition of inhibitors of RNA synthesis was 4 to 5 times more rapid than in cells exposed to a glucocorticoid (dexamethasone) which also induces the aminotransferase. Thus, it seems unlikely that cyclic AMP had been acting by stabilizing the mRNA that directs the synthesis of the aminotransferase. Possible explanations for these paradoxical results are suggested. A more rapid decline in enzyme synthesis was also seen in cells induced with both cyclic AMP and glucocorticoid, suggesting direct interaction between the two inducers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here